Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice.

[1]  A. Bizzi,et al.  Amended diagnostic protocol increases the early diagnosis of sporadic Creutzfeldt-Jakob disease , 2018, Neurology.

[2]  W. Schulz-Schaeffer,et al.  Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance , 2018, Neurology.

[3]  P. Lewczuk,et al.  CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD , 2018, Annals of clinical and translational neurology.

[4]  G. Rizzo,et al.  Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[5]  Simon Cervenka,et al.  In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings , 2017, Ageing Research Reviews.

[6]  Bernhard Hemmer,et al.  Consensus guidelines for lumbar puncture in patients with neurological diseases , 2017, Alzheimer's & dementia.

[7]  K. Blennow,et al.  High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease , 2016, Alzheimer's Research & Therapy.

[8]  K. Blennow,et al.  Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study , 2016, Alzheimer's & Dementia.

[9]  B. Hyman,et al.  Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease , 2015, Acta neuropathologica communications.

[10]  F. Pasquier,et al.  Impact of harmonization of collection tubes on Alzheimer's disease diagnosis , 2014, Alzheimer's & Dementia.

[11]  S. Haïk,et al.  The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide. , 2013, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[12]  A. Aguzzi,et al.  Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years , 2012, Brain : a journal of neurology.

[13]  W. M. van der Flier,et al.  Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort , 2012, Neurology.

[14]  A. McKee,et al.  Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease* , 2011, The Journal of Biological Chemistry.

[15]  A. Cagnin,et al.  Cerebrospinal Fluid Markers in Sporadic Creutzfeldt-Jakob Disease , 2011, International Journal of Molecular Sciences.

[16]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[17]  W. M. van der Flier,et al.  CSF biomarkers in relationship to cognitive profiles in Alzheimer disease , 2009, Neurology.

[18]  C. Duyckaerts,et al.  Alzheimer disease models and human neuropathology: similarities and differences , 2007, Acta Neuropathologica.

[19]  K. Jellinger,et al.  Neuropathological evaluation of mixed dementia , 2007, Journal of the Neurological Sciences.

[20]  K. Jellinger.  The enigma of mixed dementia , 2007, Alzheimer's & Dementia.

[21]  K. Blennow,et al.  Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury , 2006, Neurology.

[22]  J. Laplanche,et al.  Diagnostic value of CSF 14‐3‐3 detection in sporadic CJD diagnosis according to the age of the patient , 2006, European journal of neurology.

[23]  J. Wiltfang,et al.  Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease , 2002, Neurology.

[24]  Y. Agid,et al.  14‐3‐3 Protein cerebrospinal fluid detection in human growth hormone–treated Creutzfeldt‐Jakob disease patients , 2001, Annals of neurology.

[25]  K. Blennow,et al.  Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke , 2001, Neuroscience Letters.

[26]  E. Mandelkow,et al.  Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules. , 1995, Molecular biology of the cell.

[27]  F. Pasquier,et al.  Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein. , 2016, Journal of Alzheimer's disease : JAD.

[28]  F. Pasquier,et al.  Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study , 2013, Journal of Neurology.

[29]  F. Pasquier,et al.  Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study. , 2013, Journal of Alzheimer's disease : JAD.